Optimal therapy for children with high risk ALL
23 Jun 2011
Optimal therapy for children with high risk ALL
Olaparib maintenance therapy for ovarian cancer and updates from ICON7
New oncogene target for breast cancer: LMTK3
Combining oral targeted therapies shows early anti-tumour activity for advanced melanoma
Advances in breast cancer research from ASCO 2011
Vall d´Hebron Institute of Oncology; advancing personalized and targeted therapies against cancer
ASCO 2011 highlights
Advances in understanding the genetic basis of kidney cancer
The future of medicine: personalised
New models in interdisciplinary, translational and clinical research
Renal cancer 2011: novel targets
New agents for the treatment of advanced renal cancer